# Neuromed Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuromed-technologies

- Industry: Biotechnology
- Headquarters: Vancouver, Canada
- Total disclosed funding: $124M
- Latest round: Series E (Aug 21, 2007)
- Investors on record: 12

## About

Neuromed Technologies, Inc. is based in Canada and operates as a biopharmaceutical company.

## Funding rounds

- Series E, Aug 21, 2007, $53M — RBC Capital Markets, BDC Capital, GrowthWorks Capital, James Richardson & Sons, MPM BioImpact, Canadian Medical Discoveries Fund Inc.
- Series D, Mar 8, 2006, $25M — RBC Capital Markets, BDC Capital, GrowthWorks Capital, Cogene Ventures, MPM BioImpact, Canadian Medical Discoveries Fund Inc., James Richardson & Sons, Limited
- Series C, Nov 4, 2003, $32M — RBC Capital Markets, BDC Capital, GrowthWorks Capital, Cogene Ventures, MPM BioImpact, Lumira Ventures
- Series B, Mar 1, 2001, $13M — RBC Capital Markets, BDC Capital, Pictet Group, GrowthWorks Capital, Kinetic Capital, Trian Equities, Lumira Ventures

## Investors

- RBC Capital Markets (https://capitalatlas.ai/funds/rbc-capital-markets) — Series B, Series C, Series D, Series E
- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Series B, Series C, Series D, Series E
- Pictet Group — Series B
- GrowthWorks Capital (https://capitalatlas.ai/funds/growthworks-capital) — Series B, Series C, Series D, Series E
- Kinetic Capital — Series B
- Trian Equities (https://capitalatlas.ai/funds/trian-equities) — Series B
- Lumira Ventures (https://capitalatlas.ai/funds/lumira-ventures) — Series B, Series C
- Cogene Ventures (https://capitalatlas.ai/funds/cogene-ventures) — Series C, Series D
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series C, Series D, Series E
- Canadian Medical Discoveries Fund Inc. — Series D, Series E
- James Richardson & Sons, Limited — Series D
- James Richardson & Sons — Series E